News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Chrystal Paulos: Honored to Be Awarded the All-Star V Foundation grant
Chrystal Paulos/LinkedIn
Aug 3, 2025, 12:29

Chrystal Paulos: Honored to Be Awarded the All-Star V Foundation grant

Chrystal Paulos, Co-leader of the Cancer Immunology Program at Winship Cancer Institute of Emory University, shared on LinkedIn:

“Honored to be awarded the All-Star V Foundation grant! Inspired by great team efforts between my lab (Paulos) and Gregory Lesinski lab! Props to cell therapy gurus Megen Wittling, Anna Cole, Megan Wyatt and crew at Winship Cancer Institute of Emory University.”

 

All-Star V Foundation grant cancer Chrystal Paulos OncoDaily Oncology
Special Coverage
Blog
Aug 3, 2025, 12:29
Chrystal Paulos: Honored to Be Awarded the All-Star V Foundation grant
Science
Aug 3, 2025, 12:23
Al-Ola A Abdallah: Why I Believe China is Bypassing the U.S. in Cellular Therapy Innovation
Science
Aug 3, 2025, 12:15
Shankar Siva: SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma
Blog
Aug 3, 2025, 12:13
Sarah Louden: ASCO Direct 2025 in Denver 
Blog
Aug 3, 2025, 12:05
Benjamin Ebert: With Every Mile, Dana-Farber is Closer to Changing the Future of Cancer Treatment
Blog
Aug 3, 2025, 11:58
"Radiotherapy in Neuroblastoma" Educational Lectures
Blog
Aug 3, 2025, 11:55
Thein H Oo: Cancer Rehabilitation - Principles and Practice
Blog
Aug 3, 2025, 11:47
Norman Ng: The Role of Community Pharmacies in Cancer Care
Blog
Aug 3, 2025, 11:42
Binay Shah: Binaytara Oncology Survey on Ivermectin Use in Cancer Care
Blog
Aug 3, 2025, 11:41
Karen Knudsen: The Power of Science in Shifting the Narrative for Lung Cancer
Blog
Aug 3, 2025, 11:39
We’re Just Under Five Weeks Away From WCLC! - IASLC
Science
Aug 3, 2025, 11:23
Daniel Weiss: Optimizing Dosage Selection Strategies in Oncology Clinical Trials